Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation (NINBOST2018)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03805477
Recruitment Status : Recruiting
First Posted : January 15, 2019
Last Update Posted : March 27, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : February 2021